Consumer Medicine Information 2020 Template
Do not receivethis vaccineif you are allergic to any of these ingredients. What COMIRNATYlookslike COMIRNATY is a white to off-white suspension provided in a multidose clear glass vial. After dilution, each vial contains 6 doses of …
Tags:
Information, Medicine, Consumer, Do not, Consumer medicine information
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Advertisement
Documents from same domain
NEW ZEALAND DATA SHEET - Medsafe
medsafe.govt.nzTreatment of recurrent, platinum-resistant disease: 10 mg/kg body weight given once every 2 weeks when administered in combination with one of …
Madopar (levodopa) Data Sheet (DS) - Medsafe
medsafe.govt.nzMADOPAR 160202 1 Data Sheet MADOPAR® Levodopa + benserazide Capsules 62.5, 125 and 250; dispersible tablet 62.5; HBS modified-release capsule 125
Section 1: Legislation - Medsafe Home Page
medsafe.govt.nzSection 2: Overview of Regulation of Clinical Trials in New Zealand . Section summary Under Section 30 of the Medicines Act 1981, approval from the Director-General of
Section 1: Legislation relating to the labelling - …
medsafe.govt.nzPart 5, Ed 1.6 Page 2 of 18 . Section 1: Legislation relating to the labelling of medicines and related products Section summary This section lists the legislation regulating the labelling of medicines and related products.
Section, Relating, Legislation, Labelling, Section 1, Legislation relating to the labelling
NEW ZEALAND DATA SHEET VERMOX® - …
medsafe.govt.nzNEW ZEALAND DATA SHEET VERMOX® Vermox® Page 2 of 7 For control of enterobiasis Adults and children 2-12 years: 1 Vermox tablet (100 mg) or 5 mL of suspension (100 mg) is given.
Guideline on the Regulation of Therapeutic …
medsafe.govt.nzGuideline on the Regulation of Therapeutic Products in New Zealand Part 10: Requirements for information for prescribers and consumers Edition 7.0
Guidelines, Product, Regulations, Therapeutic, Guideline on the regulation of therapeutic, Guideline on the regulation of therapeutic products in
Clonazepam: oral drops (2.5 mg/ml); injection (1 mg).
medsafe.govt.nz2. you have severe and chronic lung disease 3. you have severe liver disease 4. you have an addiction to drugs or alcohol 5. the package is torn or shows signs of tampering
NEW ZEALAND DATA SHEET - Medsafe
medsafe.govt.nzNEW ZEALAND DATA SHEET 5 Hypnovel 170717 Medical history of alcohol or drug abuse Hypnovel should be avoided in patients with a medical history of alcohol or drug abuse.
SCHEDULE OF FEES (effective from 1 July 2018)
medsafe.govt.nzPage 1 of 10. SCHEDULE OF FEES (effective from 1 July 2018) • All fees listed are GST inclusive. • More detailed descriptions of the type of application or change to which a fee applies can be
Nortriptyline (as hydrochloride) 10 mg and 25 mg Tablets
medsafe.govt.nz1 Nortriptyline NRIM 09052013 NEW ZEALAND DATA SHEET Nortriptyline NRIM . Nortriptyline (as hydrochloride) 10 mg and 25 mg Tablets . This product may not be interchangeable with similar products on the New Zealand market
Related documents
Pfizer-BioNTech COVID-19 Vaccine: 12 Years of Age and ...
www.cdc.govDo NOT dilute. Administer 0.3 mL Pfizer-BioNTech COVID-19 Vaccine by intramuscular (IM) injection. name/manufacturer, lot number, and name/location of . Document vaccination. COVID-19 vaccination providers must document vaccine administration in their medical record systems within 24 hours of administration and use their best efforts to
Zendocrine - doTerra
media.doterra.comInternal use: Dilute one drop in four fluid ounces of liquid. Topical use: Apply one to two drops to desired area. Dilute with a carrier oil to minimize any skin sensitivity. See additional precautions below. CAUTIONS Possible skin sensitivity. Keep out of reach of children. If you are pregnant, nursing, or under a doctor’s care,
Safety Data Sheet Hydrogen Peroxide ... - Pro Advantage by …
www.proadvantagebyndc.comIngestion If swallowed do NOT induce vomiting and obtain immediate medical attention. Safety Data Sheet Hydrogen Peroxide 3% USP SDS Revision Date: 02/10/2015 001 - Hydrogen Peroxide 3% USP Page 3 of 8 4.2. Most important symptoms and effects, both acute and delayed
NEW ZEALAND DATA SHEET - Medsafe
medsafe.govt.nz• Do not pool excess vaccine from multiple vials. The preferred site of administration is the deltoid muscle of the upper arm. Do not inject COMIRNATY intravascularly, subcutaneously or intradermally. COMIRNATY should not be mixed in the same syringe with any other vaccines or medicinal products.
SAFETY DATA SHEET - Clorox
www.thecloroxcompany.comDo not induce vomiting unless told to do so by a poison control center or doctor. Do not give anything by mouth to an unconscious person. Call a poison control center or doctor immediately for treatment advice. Protection of First-aiders Avoid contact with skin, eyes, and clothing. Use personal protective equipment as required.
Pfizer-BioNTech COVID-19 Vaccine: 5 Years of Age and Older ...
www.cdc.govDo . NOT. use needles and syringes designated for administration to mix vaccine and diluent. Do NOT. use bacteriostatic normal saline . or other diluents. Do . NOT. use all the diluent in the vial. Do NOT. shake the vial. Do . NOT. use or save any remaining diluent to mix with additional vials of vaccine or for other uses. *Using a 21-gauge or ...